Literature DB >> 25712651

Neuroprotective effect of noscapine on cerebral oxygen-glucose deprivation injury.

Gelareh Vahabzadeh1, Nahid Rahbar-Roshandel2, Soltan-Ahmad Ebrahimi2, Massoud Mahmoudian2.   

Abstract

BACKGROUND: The present study aims to investigate the effect of noscapine (0.5-2.5 μM), an alkaloid from the opium poppy, on primary murine fetal cortical neurons exposed to oxygen-glucose deprivation (OGD), an in vitro model of ischemia.
METHODS: Cells were transferred to glucose-free DMEM and were exposed to hypoxia in a small anaerobic chamber. Cell viability and nitric oxide production were evaluated by MTT assay and the Griess method, respectively.
RESULTS: The neurotoxicities produced by all three hypoxia durations tested were significantly inhibited by 0.5 μM noscapine. Increasing noscapine concentration up to 2.5 μM produced a concentration-dependent inhibition of neurotoxicity. Pretreatment of cells with MK-801 (10 μM), a non-competitive NMDA antagonist, and nimodipine (10nM), an L-type Ca(2+) channel blockers, increased cell viability after 30 min OGD, while the application of NBQX (30 μM), a selective AMPA-kainate receptor antagonist partially attenuated cell injury. Subsequently, cells treated with noscapine in the presence of thapsigargin (1 μM), an inhibitor of endoplasmic reticulum Ca(2+) ATPases. After 60 min OGD, noscapine could inhibit the cell damage induced by thapsigargin. However, noscapine could not reduce cell damage induced by 240 min OGD in the presence of thapsigargin. Noscapine attenuated nitric oxide (NO) production in cortical neurons after 30 min OGD.
CONCLUSIONS: We concluded that noscapine had a neuroprotective effect, which could be due to its interference with multiple targets in the excitotoxicity process. These effects could be mediated partially by a decrease in NO production and the modulation of intracellular calcium levels.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Cortical culture; NO; Noscapine; Oxygen–glucose deprivation

Mesh:

Substances:

Year:  2014        PMID: 25712651     DOI: 10.1016/j.pharep.2014.10.011

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  Combination therapy for cerebral ischemia: do progesterone and noscapine provide better neuroprotection than either alone in the treatment?

Authors:  Manisha Kawadkar; Avinash S Mandloi; Nidhi Singh; Rajesh Mukharjee; Vipin V Dhote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-06       Impact factor: 3.000

2.  Chinese Medicine, Succinum, Ameliorates Cognitive Impairment of Carotid Artery Ligation Rats and Inhibits Apoptosis of HT22 Hippocampal Cells via Regulation of the GSK3β/β-Catenin Pathway.

Authors:  Chongqi Wei; Ziqiang Zhu; Jia-Ni Zheng; Yunqing Lu; Cheng Cao; Suchen Qu; Mengqiu Liu; Xue-Er Meng; Qianyin Lou; Qingqing Wang; Jin-Ao Duan; Er-Xin Shang; Zhenxiang Han; Yue Zhu
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

3.  Trans-cinnamaldehyde protected PC12 cells against oxygen and glucose deprivation/reperfusion (OGD/R)-induced injury via anti-apoptosis and anti-oxidative stress.

Authors:  Xue Qi; Ru Zhou; Yue Liu; Jing Wang; Wan-Nian Zhang; Huan-Ran Tan; Yang Niu; Tao Sun; Yu-Xiang Li; Jian-Qiang Yu
Journal:  Mol Cell Biochem       Date:  2016-08-16       Impact factor: 3.396

4.  Noscapine alleviates cerebral damage in ischemia-reperfusion injury in rats.

Authors:  Manisha Kawadkar; Avinash S Mandloi; Vidhu Saxena; Chetana Tamadaddi; Chandan Sahi; Vipin V Dhote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-27       Impact factor: 3.000

5.  The Effect of Noscapine on Oxygen-Glucose Deprivation on Primary Murine Cortical Neurons in High Glucose Condition.

Authors:  Gelareh Vahabzadeh; Soltan-Ahmed Ebrahimi; Nahid Rahbar-Roshandel; Massoud Mahmoudian
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.